Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Carlsmed (CARL) Operating Expenses (2024 - 2025)

Carlsmed (CARL) has disclosed Operating Expenses for 2 consecutive years, with $20.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Operating Expenses rose 85.33% year-over-year to $20.9 million, compared with a TTM value of $54.5 million through Dec 2025, changed N/A, and an annual FY2025 reading of $68.6 million, up 55.34% over the prior year.
  • Operating Expenses was $20.9 million for Q4 2025 at Carlsmed, up from $19.0 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $20.9 million in Q4 2025 and bottomed at $3.3 million in Q2 2025.